Navigation Links
Kosan in Medical Technology

Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breast Cancer in a Phase 2 Trial

... HAYWARD, Calif., June 3 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...emedications and ease of pharmacist preparation. kosan anticipates conducting additional studies with tan...s trastuzumab will continue on study per protocol. kosan does not plan to enroll additional patients in thi...

Kosan Announces Data Presentations at ASCO 2008 Annual Meeting

... HAYWARD, Calif., May 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...of the University of Pennsylvania. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

...AYWARD, Calif., April 16 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...all of the leukemia models tested. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer

...AYWARD, Calif., April 14 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...disease in many additional tumors. About Kosan kosan Biosciences is a biotechnology company advancing t... in a Phase 1 trial. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Initiates Phase 2 Trial of Alvespimycin, Second-Generation Hsp90 Inhibitor, in HER2-Positive Metastatic Breast Cancer

...HAYWARD, Calif., Jan. 15 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...t cancer represents a major market opportunity for kosan that we intend to pursue," said Robert G. Johnson,...hree weeks out of four weeks in repeated cycles. kosan is also testing alvespimycin delivered orally in a...

Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash

... HAYWARD, Calif., Dec. 8 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...d to be progression-free survival. About Kosan kosan Biosciences is a biotechnology company advancing t...heat shock protein 90) inhibitors and epothilones. kosan is leveraging its proprietary discovery platform t...

Kosan Presents Phase 1 Data Showing Antitumor Activity and Safety Profile of Epothilone KOS-1584 at AACR/NCI/EORTC Meeting

...HAYWARD, Calif., Oct. 23 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...pending on data from expanded dose cohorts. About kosan kosan Biosciences is a biotechnology company advancing t...

Kosan's Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial

...AYWARD, Calif., Sept. 10 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) presente...with reduced doses (one patient remains on study). kosan plans to continue to enroll patients at the 80 mg/...tion. Expanded Phase 1 Trial Includes Paclitaxel kosan has expanded the Phase 1 trial to add weekly dosin...

Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma

...HAYWARD, Calif., Sept. 6 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...e FDA's Special Protocol Assessment (SPA) process, kosan and the FDA have reached agreement on overall prot...-agent bortezomib. The Special Protocol Assessment kosan has completed applies to the TIME-1 trial. TIME-2,...

Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma

... HAYWARD, Calif., Aug. 2 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...ed primarily by the patient's level of M protein. kosan anticipates that the pivotal TIME-1 trial will beg...ion of cytotoxic proteins, leading to cell death. kosan reported data from a Phase 1b trial of tanespimyci...

Kosan's Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease

... HAYWARD, Calif., Aug. 6 /PRNewswire-FirstCall/ -- kosan Biosciences Incorporated (Nasdaq: KOSN ) today an...PF-04548043 in healthy subjects. In December 2006, kosan and Pfizer established a worldwide license agreeme... and this may improve the symptoms of GERD. About kosan ...

Kosan Announces Data Presentations at Upcoming AACR Annual Meeting

...cer therapeutics kosan Biosciences is a biotechnology company advancing t...heat shock protein 90) inhibitors and epothilones. kosan is leveraging its proprietary discovery platform t...ization agreement. For additional information on kosan Biosciences, please visit the company's website at...

Kosan Presents Data on Cardiac Safety Profile of Hsp90 Inhibitor Tanespimycin (KOS-953) at AACR

...erval can lead to ventricular arrhythmia). About kosan kosan Biosciences is a biotechnology company advancing t...heat shock protein 90) inhibitors and epothilones. kosan is leveraging its proprietary discovery platform t...

Kosan Presents Preclinical Antitumor and Safety Data On Next-Generation Epothilone KOS-1803 at AACR

...ent and duration of tumor regression was curative. kosan is currently advancing KOS-1803 through later-stag...nt in the area of cancer. In early 2007, Roche and kosan announced the decision to advance KOS-1584 into Ph...rch (AACR), being held in Los Angeles, CA. About kosan ...

Kosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR

...durability of action and a wide therapeutic index. kosan anticipates becoming the first company to advance ...r into clinical development. "We believe that kosan has established an industry-leading position in NE...ent potentially novel anticancer agents. About kosan ...

Kosan Presents Preliminary Phase 2 Data Showing Antitumor Activity of Hsp90 Inhibitor Tanespimycin in Metastatic Melanoma at ASCO

...s (with continued BRAF mutation analysis). About kosan kosan Biosciences is a biotechnology company advancing t...heat shock protein 90) inhibitors and epothilones. kosan is leveraging its proprietary discovery platform t...

Kosan Presents Data on Lead Hsp90 Inhibitor, Tanespimycin, Showing Promising Antitumor Activity in Multiple Myeloma at ASCO

...nd patients treated with bortezomib alone. About kosan kosan Biosciences is a biotechnology company advancing t...heat shock protein 90) inhibitors and epothilones. kosan is leveraging its proprietary discovery platform t...

Kosan Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Epothilone KOS-1584 at ASCO

...-small cell lung cancers and sarcomas. Roche and kosan plan to advance KOS-1584/R1645 into Phase 2 trials...ty with established chemotherapy regimens. About kosan kosan Biosciences is a biotechnology company advancing t...

Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO

...ans to add paclitaxel (Taxol(R)) to the regimen. kosan plans to initiate a Phase 2 study of alvespimycin ...b. This trial will be conducted in Eastern Europe. kosan anticipates that regulatory filings to support ini...clinical trial will be completed by mid-year 2007. kosan plans to initiate a larger, international Phase 2/...
Other Tags
(Date:8/19/2014)... students in college biology and other science courses ... quantitative ways, and now they have a new ... the Life Sciences," published this month by Princeton ... Institute for Mathematical and Biological Synthesis (NIMBioS), teaches ... can be used to explore and explain biological ...
(Date:8/19/2014)... of UTSA researchers has been awarded a nearly $40,000 ... Training (NCPTT), an office of the National Park Service ... will fund a one-year study of the energy efficiency ... homes in hot, humid climates. , Radiant barriers are ... that reflect heat back, thereby reducing the amount of ...
(Date:8/19/2014)... a number of ways. They have an impressive ability ... After being struck by lightning, for example, a tree ... one major downside to life as a plant: They ... they live and therefore completely at the mercy of ... developed mechanisms that enable them to rapidly adapt their ...
Breaking Biology News(10 mins):New textbook introduces undergraduates to mathematics for the life sciences 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3How steroid hormones enable plants to grow 2
(Date:8/20/2014)... August 20, 2014 It’s no secret ... According to the National Institute on Drug Abuse, nearly ... drugs. What’s even more alarming is the fact that ... last decade. , Those locked in a struggle with ... way out. But now, the newly-redesigned AbuseTreatmentCenters.net has released ...
(Date:8/20/2014)... 20, 2014 One Call Alert expands its ... of ResCube, a fully-mobile wearable device that connects customers to ... button, 24 hours a day, 365 days a year. , ... cross country. It operates on the T-Mobile nationwide network like ... in to work. , Like with the other One Call ...
(Date:8/20/2014)... at the Universities of Manchester and Auckland suggest that both ... mechanism. , The findings, published today in the ... or type-1 diabetes and type-2 diabetes are both caused by ... , The results, based on 20 years, work ... both be slowed down and potentially reversed by medicines that ...
(Date:8/20/2014)... Fresh from the cradle of a world-class running city, an ... , Urbini, a new collection of versatile baby gear from ... jogger to its lineup. , The Avi has been in ... the latest racing styles and a set of features to ... a swift, smooth ride on runs, power-walks and causal strolls. ...
(Date:8/20/2014)... 20, 2014 Today, Zane Benefits, the ... open enrollment for 2015. , According to Zane Benefits, ... in November, employees are encouraged to start thinking about ... 2015, the open enrollment period will run from November ... 2015 individuals can purchase a new individual health insurance ...
Breaking Medicine News(10 mins):Health News:Re-Launched AbuseTreatmentCenters.net Offering New List of Substance Abuse Resources 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 2Health News:One Call Alert Introduces ResCube™, Smallest Mobile Medical Alert System on Market 3Health News:Scientists show type-1 and type-2 diabetes are caused by same underlying mechanism 2Health News:Urbini Breezes Through Summer with New Jogging Stroller 2
Other Contents